Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01638078

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01638078
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01638078. Randomized; quadruple masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation
Acronym
TOP RACER
Intervention (Drug)
Thalidomide
Intervention (Drug)
Placebo
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01638078
Content hash
7529a1b1dd3762292241a66026031045646e7f2bc56c16c10a2c2cd0d175bfbb